drugset / Trial / NCT00483977

A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee

NCT00483977

Phase 2 Terminated 113 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary aim is to assess if PF-00592379 is able to reduce pain in patients with osteoarthritis of the knee.

Timeline

Start
2007-06
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxycodone Other / unclassified 20 mg Oral
Subject PF-000592379 Unknown 30 mg Oral

Indications